Filter
1409
Filtered Results: 1409
Text search:
Tuberculosis
treatment
success
rates
Featured
Recommendations
112
New Publications
457
Language
Document type
No document type
997
Studies & Reports
208
Guidelines
98
Manuals
43
Strategic & Response Plan
37
Training Material
9
Fact sheets
7
Infographics
4
Situation Updates
3
Resource Platforms
3
Countries / Regions
India
65
Kenya
48
Western and Central Europe
46
Global
42
Nigeria
36
Zambia
35
Tanzania
33
South Africa
33
Ethiopia
33
Uganda
32
Rwanda
30
Nepal
28
Bangladesh
27
Sierra Leone
25
Eastern Europe
25
Malawi
24
Asia
23
Myanmar / Burma
21
Africa
20
Namibia
20
Liberia
20
Lesotho
19
Ghana
19
Latin America and the Carribbean
18
South–East Asia Region
17
Cambodia
14
Botswana
12
Philippines
10
Zimbabwe
9
Senegal
8
East and Southern Africa
8
Ukraine
7
Mozambique
7
Indonesia
7
Pakistan
6
Germany
5
Sudan
5
Georgia
5
South Sudan
5
Tajikistan
4
Syria
4
Albania
4
Haiti
4
Jordan
4
Congo, Democratic Republic of
4
Russia
4
Eswatini/ Swaziland
4
Timor Leste/ East Timor
3
Benin
3
Cameroon
3
Afghanistan
3
Guinea
3
Western Pacific Region
3
Lebanon
3
Colombia
2
Thailand
2
Iran
2
Burkina Faso
2
Peru
2
Saudi Arabia
2
West and Central Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Paraguay
2
Moldova
2
Sri Lanka
2
Bhutan
2
Iraq
2
Somalia
2
North Korea
1
El Salvador
1
Gambia
1
Laos
1
Morocco
1
Qatar
1
Armenia
1
Venezuela
1
North America
1
Gabon
1
Tunisia
1
United Kingdom
1
Argentina
1
Vietnam
1
Djibouti
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Central African Republic
1
Mali
1
Libya
1
Authors & Publishers
Publication Years
Category
Countries
619
Clinical Guidelines
94
Public Health
92
Women & Child Health
41
Key Resources
31
Capacity Building
15
Pharmacy & Technologies
12
Annual Report MEDBOX
1
Toolboxes
TB
267
HIV
227
AMR
47
Global Health Education
32
Mental Health
31
COVID-19
30
NTDs
30
Planetary Health
22
NCDs
22
Caregiver
21
Rapid Response
16
Conflict
15
Pharmacy
14
Refugee
12
Disability
12
Health Financing Toolbox
11
Polio
11
Ebola
7
Natural Hazards
3
Specific Hazards
1
Cholera
1
Social Ethics
1
In Paraguay, 1.8% of the population are indigenous people. The Maká community
29 mainly live in urbanized areas in the Central Region. This study focuses on the epidemiology
30 of tuberculosis (TB) among indigenous Maká and the non-indigenous people living in the
31 Central Region, the biggest ...
Diagnosis and Treatment Outcomes of Tuberculosis in Relation to Gender and HIV Status in South Benin
Journal of Tuberculosis Research, 2017, 5, 189-200
Background: In Benin, little is known about the influence of both gender and
HIV-status on diagnostic patterns and treatment outcomes of Tuberculosis
(TB) patients. Objective: To assess whether differences in gender and HIV
status affect diagn...
Tuberculosis (TB) prevention is essential for reaching the End TB targets in the South-East Asia Region (SEAR) of World Health Organization (WHO)1. The targets of 80% reduction in TB incidence rate and 90% reduction in TB mortality by 2030 (compared to 2015 levels) can be achieved only with addition...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T...
Investigación original / Original research
Panam Salud Publica. 2016;39(1):38–43.
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retro...
Guidelines for treatment of drug-susceptible tuberculosisand patient care
2017 Update
Antimicrobial Resistance and Infection Control 2014,3 :31
Medicina (Kaunas) 2013;49(7):335-40
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...
4th edition. This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition
